Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
India may issue a warning over cough syrup exported by Marion Biotech linked to a death in Uzbekistan.
Read Full NewsMargaret Rice, PhD, a professor in the Departments of Neurosurgery and Neuroscience at NYU Grossman School of Medicine, provided answers on recently published preclinical research relating aerobic exercise to dopamine release and coordination in PD.
FDA Issues Complete Response Letter for ONS-5010 for Wet AMD
10 FDA Headlines You Missed in December 2025
Dermatology in 2025: Year in Review
1.
Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975
2.
Good News for CAR-T Therapy; Liquid Biopsy Progress; Anti-Psychotic for Brain Cancer
3.
Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?
4.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
5.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
1.
Unlocking the Potential of SABCS 2022: Innovative Strategies for Cancer Research
2.
The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies
3.
Leptomeningeal Carcinomatosis: Symptoms, Causes, and Treatment Options
4.
Lymphomatoid Papulosis: What You Need to Know
5.
Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body?
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge